trial

Confirmatory Trial of Gamma Neurofeedback to Improve Working Memory in Schizophrenia

NCTId NCT07592169
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 2 · Not Yet Recruiting
Enrollment 104 (estimated)
Sponsored by University of California Riverside at C.I. Trials, Inc.-Inland Empire
Primary completion 2029-11-30
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 2
Status
Not Yet Recruiting
Enrollment
104 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Triple
Start
2026-06-01
Primary completion
2029-11-30
Eligibility
ALL · 18 Years · 55 Years

Interventions & indications

Drugs
EEG Neurofeedback

Sponsors

University of California Riverside at C.I. Trials, Inc.-Inland EmpireLead Sponsor

Investigators

1
Fiza Singh, MDPrincipal Investigator

Sites

0 total

Linked catalysts

1
Confirmatory Trial of Gamma Neurofeedback to Improve Working Memory in Schizophr — primary completion2029-11-30

Facts & assertions

4 sourced
Enrollment
104
Phase
PHASE2
Primary Completion Date
2029-11-30
Status
NOT_YET_RECRUITING
relationships
The graph out of here
drug
EEG Neurofeedback
drug
lead_sponsor
University of California Riverside at C.I. Trials, Inc.-Inland Empire
company
indication
Schizoaffecitve Disorder
indication
Schizophrenia
indication
SCHIZOPHRENIA 1 (Disorder)
indication
investigator
Fiza Singh, MD
person